Mitsubishi Pharma Europe

Mitsubishi Tanabe Pharma Europe is the European subsidiary of Mitsubishi Tanabe Pharma Corporation, a leading Japanese pharmaceutical company. Headquartered in London, the company focuses on the development and commercialization of innovative therapies for unmet medical needs, with a primary emphasis on neurology, immunology, and rare diseases. The company manages clinical trials, regulatory affairs, and marketing activities across the European region, supporting a portfolio that includes treatments for Amyotrophic Lateral Sclerosis (ALS) and Parkinson's disease. As part of the Mitsubishi Chemical Group, it leverages global research capabilities to bring specialized medicines to the European market.